[1] BIRKENBEUEL J L,PANG J C,LEE A,et al.Long-term outcomes in sinonasal squamous cell carcinoma arising from inverted papilloma:Systematic review[J].Head Neck,2022,44(4):1014-1029. [2] NIE D,WANG X,SUN M,et al.The primary site of head and neck squamous cell carcinoma predicts survival benefits of EGFR inhibitors:A systematic review and meta-analysis[J].Radiother Oncol,2021,158:13-20. [3] MELO B A C,VILAR L G,OLIVEIRA N R,et al.Human papillomavirus infection and oral squamous cell carcinoma - a systematic review[J].Braz J Otorhinolaryngol,2021,87(3):346-352. [4] AI Q H,HUNG K F,SO T Y,et al.Prognostic value of cervical nodal necrosis on staging imaging of nasopharyngeal carcinoma in era of intensity-modulated radiotherapy:A systematic review and meta-analysis[J].Cancer Imaging,2022,22(1):24. [5] 中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2015版)[J].中国癌症杂志,2015,25(9):692-754. [6] CHEN Y P,ISMAILA N,CHUA MLK,et al.Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma:CSCO and ASCO guideline[J].J Clin Oncol,2021,39(7):840-859. [7] 梁锐根,关燕鸣,胡力.液基细胞学检查联合SCCA、CA153检测对宫颈癌诊断的应用研究[J].广州医药,2022,53(5):43-46. [8] GULER O C,ONAL C.Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive(chemo)radiotherapy:A systematic review and metaanalysis.In regard to De Virgilio et al[J].J Cancer Res Clin Oncol,2022,148(9):2567-2568. [9] BOTTICELLI A,CIRILLO A,STRIGARI L,et al.Anti-PD-1 and Anti-PD-L1 in head and neck cancer:A network Meta-Analysis[J].Front Immunol,2021(12):705096. [10] 杨蜜,张加勇,张欣平,等.免疫治疗联合热疗加放疗治疗老年中晚期宫颈癌的疗效及安全性[J].现代肿瘤医学,2024,32(1):125-129. [11] 铁好,李丽蓉,石丽梅,等.宫颈癌同步放化疗患者症状群及影响因素研究[J].中华现代护理杂志,2023,29(33):4601-4607. [12] 蒋清华,陈月梅,张仁静.中晚期宫颈癌同步放化疗患者症状群困扰及其与生活质量的相关性研究[J].重庆医学,2023,52(2):225-229,234. [13] 陈希伟,郑晓玲,陈小岑,等.中青年宫颈癌同步放化疗患者配偶二元应对现状及影响因素分析[J].中国实用护理杂志,2023,39(21):1657-1664. [14] 吕芸,施晓,孙运明,等.益气解毒方对宫颈癌同步放化疗脾虚型患者治疗效果及对肿瘤标志物的影响[J].中华中医药学刊,2023,41(9):254-258. [15] 李月,赖巧蓉,周娟,等.宫颈癌术后同步放化疗患者自我管理现状及其影响因素的研究[J].中国性科学,2023,32(4):59-62. [16] 刘会岭,崔永斌,常诚,等.CT影像组学预测局部晚期宫颈癌同步放化疗后生存期[J].中华放射肿瘤学杂志,2023,32(8):697-703. [17] 陈宝杰,杜丹,邓宇,等.106例局部晚期宫颈癌根治性同步放化疗的临床疗效及预后影响因素[J].现代妇产科进展,2023,32(3):207-213. [18] 李凤虎,梅烦,杜燕军,等.新辅助化疗对比同步放化疗对宫颈癌放疗剂量影响的研究[J].中华放射肿瘤学杂志,2023,32(2):131-137. [19] 张羽,苏日新,张凯悦,等.基于临床及影像学参数预测宫颈癌患者同步放化疗后生存[J].中华放射肿瘤学杂志,2023,32(1):28-35. [20] 刘超霞,冉晓敏,张克强,等.淋巴结转移的局部晚期宫颈癌行PD-1抑制剂联合同步放化疗的疗效及安全性研究[J].中国肿瘤临床,2023,50(8):418-422. [21] 何花,胡文滕,马敏杰,等.诱导化疗或放化疗后手术切除和同步放化疗治疗ⅢA-N2期非小细胞肺癌疗效的系统评价与Meta分析[J].中国胸心血管外科临床杂志,2023,30(1):133-139. [22] 李月,姬春晖,蒋宇,等.宫颈癌术后放化疗患者失志现状、影响因素及对策[J].现代临床护理,2023,22(7):8-14. |